Latest stories on BCDA
BioCardia Highlights Therapeutic Pipeline at Investor Conference
TipRanks56 · neutralproduct/pr
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K50 · neutralgeneral
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralproduct/pr
BioCardia gets FDA confirmation of Helix meeting minutes
The Fly65 · bullishgeneral
BioCardia Advances Helix Catheter Toward De Novo Approval
TipRanks63 · neutralproduct/pr
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K50 · neutralgeneral
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval
Business Insider67 · bullishproduct/pr
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K34 · bearishgeneral
BioCardia (BCDA) Q2 2026 Earnings Call Transcript
The Motley Fool59 · neutralearnings
Biocardia outlines Japan CardiAMP Shonin submission next quarter with approval expected about 12 months later
Seeking Alpha63 · neutralproduct/pr
BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K50 · neutralgeneral
BioCardia GAAP EPS of -$0.13 beats by $0.05
Seeking Alpha56 · neutralearnings
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
StockTitan59 · neutralearnings
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
GlobeNewswire56 · neutralearnings
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
StockTitan50 · neutralgeneral
BioCardia Outlines 2026 CardiAMP Strategy and Milestones
TipRanks56 · neutralproduct/pr
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K50 · neutralgeneral
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities | BCDA Stock News
StockTitan56 · neutralgeneral
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K34 · bearishgeneral
BioCardia Raises $4.4 Million to Extend Cash Runway
TipRanks28 · bearishgeneral
BioCardia, Inc. (BCDA) files 8-K
SEC 8-K50 · neutralgeneral
BioCardia Announces $4.4 Million Financing | BCDA Stock News
StockTitan28 · bearishgeneral
BioCardia Gains FDA Path for CardiAMP PMA Approval
TipRanks67 · bullishproduct/pr
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF | BCDA Stock News
StockTitan73 · bullishproduct/pr